Darrin Disley
Direttore/Membro del Consiglio presso ROQUEFORT THERAPEUTICS PLC
Patrimonio netto: 82 409 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Darrin Disley
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 9 | |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom.
9
| Subsidiary | Biotechnology | 9 |
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million.
2
| Subsidiary | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Darrin Disley tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
| King's College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
Desktop Genetics Ltd.
 Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member Director/Board Member | |
| University College London | College/University | Doctorate Degree Corporate Officer/Principal | |
| ONDINE BIOMEDICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Tibotec Pharmaceuticals | Director of Finance/CFO | ||
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Delaware | College/University | Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Medical Specialties | Director of Finance/CFO | |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director of Finance/CFO | |
Calon Cardio-Technology Ltd.
 Calon Cardio-Technology Ltd. Medical SpecialtiesHealth Technology Calon Cardio-Technology Ltd. develops implantable micro blood pumps for the treatment of chronic heart failure. Its lead product, the MiniVAD, a miniature implantable blood pump, is being developed for implantation directly into the left ventricle of the failing heart to help provide adequate blood supply to the body, alleviate the debilitating symptoms of heart failure and improve quality of life. The company was founded by Marc Clement in 2007 and is headquartered in Swansea, the United Kingdom. | Medical Specialties | Founder | |
| University of Cardiff | College/University | President | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OXURION NV | Pharmaceuticals: Major | Chief Executive Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| University of London | College/University | Undergraduate Degree | |
European Hydrocarbons Ltd.
 European Hydrocarbons Ltd. Oil & Gas ProductionEnergy Minerals European Hydrocarbons Ltd. explores oil and gas properties. The company was founded in 1997 and is headquartered in London, UK | Oil & Gas Production | Director/Board Member | |
| Silk Road Oil & Gas Ltd. | Director/Board Member | ||
Orana Corporate LLP
 Orana Corporate LLP Miscellaneous Commercial ServicesCommercial Services Orana Corporate LLP is a boutique corporate advisory and services practice that partners with high growth businesses to maximize their potential through effective advice and teamwork. The private company is based in London, UK and has subsidiaries in the United Kingdom. The British company's team consists primarily of chartered accountants and corporate finance professionals with extensive experience dealing with quoted and private companies operating in a variety of sectors and jurisdictions. | Miscellaneous Commercial Services | Director/Board Member | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
XiMo AG
 XiMo AG Chemicals: SpecialtyProcess Industries XiMo AG develops catalysts for the metathesis of organic compounds. The firm catalyst development, process development and reactor design. The firm serves in the area of agrochemicals, flavors and fragrances, pharmaceuticals, polymers, oils and waxes and surface treatments sectors. The company was founded by Richard Schrock and Amir Hoveyda in 2010 and is headquartered in Lucerne, Switzerland. | Chemicals: Specialty | Founder | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Imperial College London | College/University | Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| The University of Sydney | College/University | Graduate Degree | |
| Trinity College Dublin | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
Summa Equity AB
 Summa Equity AB Investment ManagersFinance Summa Equity AB (Summa Equity) is a private equity firm founded in 2016 by Jenny Keisu, Reynir Kjær Indahl and Johannes Hidle Lien. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor | |
International Integrated Reporting Council
 International Integrated Reporting Council Miscellaneous Commercial ServicesCommercial Services The International Integrated Reporting Council operates a council focused on integrated reporting. Richard Stuart Howitt has been the CEO of the American company since 2016. | Miscellaneous Commercial Services | Chairman | |
McKinsey & Company Holdings Ltd.
 McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Part of McKinsey & Co., Inc., McKinsey & Company Holdings Ltd. is a consulting firm that partners with leaders on strategy, innovating to net zero, leading with tech, and building capabilities for a sustainable, inclusive, growing future. The company is based in London, UK. The British company specializes in Consumer Packaged Goods and has conducted research, articles, and reports on the changes that matter most for the challenges and opportunities ahead. The company was founded in 2011 by Brian K. Stafford. | Financial Conglomerates | Corporate Officer/Principal | |
| Alan Turing Institute | Chairman |
Statistiche
Distribuzione geografica
| Regno Unito | 20 |
| Stati Uniti | 17 |
| Svizzera | 5 |
| Irlanda | 3 |
| Canada | 2 |
Settori
| Consumer Services | 18 |
| Health Technology | 14 |
| Finance | 5 |
| Commercial Services | 4 |
| Energy Minerals | 4 |
Posizioni
| Director/Board Member | 123 |
| Corporate Officer/Principal | 22 |
| Chairman | 20 |
| Founder | 20 |
| Chief Tech/Sci/R&D Officer | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Stephen Paul West | 28 |
| Chaim Hurvitz | 25 |
| Jean Duvall | 22 |
| Mark Freeman | 16 |
| Michael Stein | 12 |
| Gary Pisano | 11 |
| Simon Sinclair | 11 |
| Thomas Graney | 11 |
| Ajan Reginald | 10 |
| Conor Kehoe | 9 |
| Armand Keating | 8 |
| Jane Osbourn | 6 |
| Martin Evans | 6 |
| Fiona Murray | 4 |
| Graham Robertson | 4 |
- Borsa valori
- Insiders
- Darrin Disley
- Connessioni Società
